Aurinia Pharmaceuticals Inc. (AUPH) Gross profit 2019–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual gross profit history from SEC filings — each fiscal year as reported.
$250.4MFY2025 · since FY2019: $318,000 → $250.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $250.4M | +21.0% |
| FY2024 | $206.9M | +28.2% |
| FY2023 | $161.4M | +25.7% |
| FY2022 | $128.4M | +188.4% |
| FY2021 | $44.5M | -11.2% |
| FY2020 | $50.1M | +15660.4% |
| FY2019 | $318,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Net marginAUPH Gross marginAUPH Operating incomeAUPH Operating marginAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →